[
    [
        {
            "time": "",
            "original_text": "「医药速读社」孙飘扬个人斥资3.16亿加码新药公司",
            "features": {
                "keywords": [
                    "孙飘扬",
                    "斥资",
                    "新药公司"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "「医药速读社」孙飘扬个人斥资3.16亿加码新药公司",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "速读社丨孙飘扬个人斥3.16亿加码新药公司 复宏汉霖港交易所摘“B”",
            "features": {
                "keywords": [
                    "孙飘扬",
                    "复宏汉霖",
                    "港交易所",
                    "摘B"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "速读社丨孙飘扬个人斥3.16亿加码新药公司 复宏汉霖港交易所摘“B”",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【权益变动】药明康德(02359-HK)获FILLimited增持53.95万股",
            "features": {
                "keywords": [
                    "药明康德",
                    "增持",
                    "FILLimited"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【权益变动】药明康德(02359-HK)获FILLimited增持53.95万股",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "粤开医药研究|网售处方药全面放开，第五批带量采购箭在弦上",
            "features": {
                "keywords": [
                    "网售处方药",
                    "带量采购"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "粤开医药研究|网售处方药全面放开，第五批带量采购箭在弦上",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【行情】港股医药外包概念股短线异动走高，药明生物跌幅缩窄至1.2%，康龙化成跌幅缩窄至0.5%，药明康德涨0.12%，金斯瑞生物科技涨3.3%",
            "features": {
                "keywords": [
                    "港股",
                    "医药外包",
                    "药明生物",
                    "康龙化成",
                    "药明康德",
                    "金斯瑞生物科技"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【行情】港股医药外包概念股短线异动走高，药明生物跌幅缩窄至1.2%，康龙化成跌幅缩窄至0.5%，药明康德涨0.12%，金斯瑞生物科技涨3.3%",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "八大券商主题策略：A股医药行业龙头名单精选 这些都是核心赛道！",
            "features": {
                "keywords": [
                    "券商",
                    "主题策略",
                    "A股",
                    "医药行业",
                    "龙头"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "八大券商主题策略：A股医药行业龙头名单精选 这些都是核心赛道！",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "每日“药”闻| 11亿！福泰制药加注基因编辑疗法；礼来巴瑞替尼治疗斑秃结果显着",
            "features": {
                "keywords": [
                    "福泰制药",
                    "基因编辑疗法",
                    "礼来",
                    "巴瑞替尼",
                    "斑秃"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "每日“药”闻| 11亿！福泰制药加注基因编辑疗法；礼来巴瑞替尼治疗斑秃结果显着",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "银华李晓星最新持仓：减持五粮液、药明康德 大举增持腾讯控股 减持股份",
            "features": {
                "keywords": [
                    "银华李晓星",
                    "减持",
                    "五粮液",
                    "药明康德",
                    "增持",
                    "腾讯控股"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技",
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "银华李晓星最新持仓：减持五粮液、药明康德 大举增持腾讯控股 减持股份",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]